MAO Enzyme May Become Biomarker of Alzheimer’s Diagnosis and Progression

MAO Enzyme May Become Biomarker of Alzheimer’s Diagnosis and Progression
An enzyme called monoamine oxidase (MAO) may become a biomarker for the diagnosis and progression of Alzheimer’s disease, according to a new study. The study, “Close Correlation Of Monoamine Oxidase Activity With Progress Of Alzheimer’s Disease In Mice, Observed By In Vivo Two-Photon Imaging,” was published in the journal ACS Central Science. A hallmark of

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *